This assay is used for screening and profiling OX40 (Human) binding molecules (such as anti-OX40 antibody, ADC) in a cellular context. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.
Features
Customized to client's specific requirements
Target Cell Name
HEK293/OX40 (Human)
Target Cell Organism
Human
Target Cell Background
Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant HEK293 stably expressing human OX40 (TNF receptor superfamily member 4, TNFRSF4, ACT35; CD134; IMD16; TXGP1L, GenBank Accession #NM_003327). Which can be used in binding assays and functional assay.
Target Cell Alternative Name
HEK293
Related Diseases
Cancer
Research Area
Oncology
Assay Name
In Vitro Cell Binding Assay
Short Description
Screening and profiling for OX40 (Human) binding molecules (such as anti-OX40 antibody, ADC) in a cellular context.
Assay Description
Drug candidates screening and profiling assay as a most important analysis for drug discovery. Creative Biolabs provides In Vitro OX40 (Human) Binding Molecules Screening Assay to screen OX40 (Human) binding molecules (such as anti-OX40 antibody, ADC) by cell-based binding FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.
Assay Alternative Names
Cell-based Binding Assay; Drug Screening and Profiling assay
Assay Type
Cell Binding Assay
Assay Type Details
Screening and profiling OX40 (Human) binding molecules (such as anti-OX40 antibody, ADC) by cell-based binding FACS analysis.
Assay MOA
Creative have developed the stable cell line HEK293/OX40 (Human), which is designed for screening and profiling OX40 (Human) binding molecules (such as anti-OX40 antibody, ADC) by cell-based binding FACS analysis.